Whether a merlot, chardonnay or pinot noir is more pleasing to your palate, if you’ve had a recent glass of wine in Australia or the UK, there’s at least a decent chance it came from Accolade Wines. With roots winding back to 1853, the company claims to be the top wine seller in both countries, producing 35 million cases of the stuff every year.
Until 2011, though, Accolade didn’t exist. At least not in its current form. At the time, the businesses that today comprise Accolade were simply the Australian and UK units of Constellation Brands, a wine, beer & spirits giant publicly traded on the NYSE. It wasn’t until the divisions drew the attention of a private equity firm that the company took its current name.
That firm was Champ Private Equity, which acquired an 80% stake in the Australian and UK businesses from Constellation on January 31, 2011, in a deal that valued the wine producer at A$290 million (or about $289 million at the historic conversion rate). The deal was right in line with the longtime Australian investor’s usual strategy: Champ typically targets companies valued at between A$100 million and A$750 million, with a focus on sectors including education, food & beverage and healthcare.
Constellation kept a 20% stake in Accolade as part of the deal, maintaining a valuable connection between the company and one of the alcohol industry’s biggest names: As of this writing, Constellation has a market cap of more than $30 billion.
It wasn’t long before Accolade forged financial ties to another major name. Several months after its acquisition by Champ, the company raised more than $200 million through a financing facility from GE Capital. Three years later, in 2014, GE Capital gave another $300 million in financing to the company, taking its total commitment well past $500 million. Accolade used all that cash to reshape its balance sheet and continue spreading its global reach.
And eventually, Champ began sniffing around for an exit. In 2016, the firm reportedly hired Reunion Capital Partners to advise on a possible IPO the next year. Weeks later, reports emerged that Champ was instead discussing a sale of Accolade with two separate Chinese conglomerates—a product in part of China’s growing appetite for Australian wines—as well as British private equity firm Permira. But the price apparently wasn’t right.
In the end, it would be almost another two years before Champ and Constellation found a deal. In April 2018, the co-owners agreed to sell 100% of Accolade to The Carlyle Group for A$1 billion, with cash for Carlyle’s investment coming from its fourth Asia fund.
A valuation increase of more than 3x in the span of eight years? That calls for a toast.
Learn about our editorial standards.